[
    "{\"step_by_step_thinking\": \"The documents mention that Pneumocystis jirovecii is a common cause of pneumonia in patients with cancer-related immunosuppression, including those undergoing chemotherapy. The documents also mention that prophylaxis is highly effective and should be given to all patients at moderate to high risk of Pneumocystis jirovecii infection. The drug of choice for prophylaxis and treatment is Trimethoprim-sulfamethoxazole, also known as cotrimoxazole. Therefore, the answer is cotrimoxazole.\", \"answer_choice\": \"A\"}"
]